Your browser doesn't support javascript.
loading
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches.
Welsh, Joshua A; Goberdhan, Deborah C I; O'Driscoll, Lorraine; Buzas, Edit I; Blenkiron, Cherie; Bussolati, Benedetta; Cai, Houjian; Di Vizio, Dolores; Driedonks, Tom A P; Erdbrügger, Uta; Falcon-Perez, Juan M; Fu, Qing-Ling; Hill, Andrew F; Lenassi, Metka; Lim, Sai Kiang; Mahoney, My G; Mohanty, Sujata; Möller, Andreas; Nieuwland, Rienk; Ochiya, Takahiro; Sahoo, Susmita; Torrecilhas, Ana C; Zheng, Lei; Zijlstra, Andries; Abuelreich, Sarah; Bagabas, Reem; Bergese, Paolo; Bridges, Esther M; Brucale, Marco; Burger, Dylan; Carney, Randy P; Cocucci, Emanuele; Crescitelli, Rossella; Hanser, Edveena; Harris, Adrian L; Haughey, Norman J; Hendrix, An; Ivanov, Alexander R; Jovanovic-Talisman, Tijana; Kruh-Garcia, Nicole A; Ku'ulei-Lyn Faustino, Vroniqa; Kyburz, Diego; Lässer, Cecilia; Lennon, Kathleen M; Lötvall, Jan; Maddox, Adam L; Martens-Uzunova, Elena S; Mizenko, Rachel R; Newman, Lauren A; Ridolfi, Andrea.
Affiliation
  • Welsh JA; Translational Nanobiology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Goberdhan DCI; Nuffield Department of Women's and Reproductive Health, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford, UK.
  • O'Driscoll L; School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland.
  • Buzas EI; Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
  • Blenkiron C; Trinity St. James's Cancer Institute, Trinity College Dublin, Dublin, Ireland.
  • Bussolati B; Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary.
  • Cai H; HCEMM-SU Extracellular Vesicle Research Group, Semmelweis University, Budapest, Hungary.
  • Di Vizio D; HUN-REN-SU Translational Extracellular Vesicle Research Group, Semmelweis University, Budapest, Hungary.
  • Driedonks TAP; Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
  • Erdbrügger U; Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
  • Falcon-Perez JM; University of Georgia, Athens, Georgia, USA.
  • Fu QL; Department of Surgery, Division of Cancer Biology and Therapeutics, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Hill AF; Department CDL Research, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Lenassi M; University of Virginia Health System, Charlottesville, Virginia, USA.
  • Lim SK; Exosomes Laboratory, Center for Cooperative Research in Biosciences, Basque Research and Technology Alliance, Derio, Spain.
  • Mahoney MG; Metabolomics Platform, Center for Cooperative Research in Biosciences, Basque Research and Technology Alliance, Derio, Spain.
  • Mohanty S; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.
  • Möller A; Otorhinolaryngology Hospital, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Nieuwland R; Extracellular Vesicle Research and Clinical Translational Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Ochiya T; Institute for Health and Sport, Victoria University, Melbourne, Australia.
  • Sahoo S; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Torrecilhas AC; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
  • Zheng L; Paracrine Therapeutics Pte. Ltd., Singapore, Singapore.
  • Zijlstra A; Department of Surgery, YLL School of Medicine, National University Singapore, Singapore, Singapore.
  • Abuelreich S; Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Bagabas R; Stem Cell Facility, All India Institute of Medical Sciences, New Delhi, India.
  • Bergese P; Chinese University of Hong Kong, Hong Kong, Hong Kong S.A.R.
  • Bridges EM; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
  • Brucale M; Laboratory of Experimental Clinical Chemistry, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Burger D; Amsterdam Vesicle Center, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Carney RP; Tokyo Medical University, Tokyo, Japan.
  • Cocucci E; Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Crescitelli R; Laboratório de Imunologia Celular e Bioquímica de Fungos e Protozoários, Departamento de Ciências Farmacêuticas, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo (UNIFESP) Campus Diadema, Diadema, Brazil.
  • Hanser E; Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Harris AL; Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Haughey NJ; Genentech, South San Francisco, California, USA.
  • Hendrix A; Department of Molecular Medicine, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
  • Ivanov AR; Department of Molecular Medicine, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
  • Jovanovic-Talisman T; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
  • Kruh-Garcia NA; Center for Colloid and Surface Science (CSGI), Florence, Italy.
  • Ku'ulei-Lyn Faustino V; National Center for Gene Therapy and Drugs based on RNA Technology, Padua, Italy.
  • Kyburz D; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Lässer C; Consiglio Nazionale delle Ricerche - Istituto per lo Studio dei Materiali Nanostrutturati, Bologna, Italy.
  • Lennon KM; Consorzio Interuniversitario per lo Sviluppo dei Sistemi a Grande Interfase, Florence, Italy.
  • Lötvall J; Kidney Research Centre, Ottawa Hopsital Research Institute, Ottawa, Canada.
  • Maddox AL; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Canada.
  • Martens-Uzunova ES; School of Pharmaceutical Sciences, University of Ottawa, Ottawa, Canada.
  • Mizenko RR; Department of Biomedical Engineering, University of California, Davis, California, USA.
  • Newman LA; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.
  • Ridolfi A; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.
J Extracell Vesicles ; 13(2): e12404, 2024 Feb.
Article in En | MEDLINE | ID: mdl-38326288
ABSTRACT
Extracellular vesicles (EVs), through their complex cargo, can reflect the state of their cell of origin and change the functions and phenotypes of other cells. These features indicate strong biomarker and therapeutic potential and have generated broad interest, as evidenced by the steady year-on-year increase in the numbers of scientific publications about EVs. Important advances have been made in EV metrology and in understanding and applying EV biology. However, hurdles remain to realising the potential of EVs in domains ranging from basic biology to clinical applications due to challenges in EV nomenclature, separation from non-vesicular extracellular particles, characterisation and functional studies. To address the challenges and opportunities in this rapidly evolving field, the International Society for Extracellular Vesicles (ISEV) updates its 'Minimal Information for Studies of Extracellular Vesicles', which was first published in 2014 and then in 2018 as MISEV2014 and MISEV2018, respectively. The goal of the current document, MISEV2023, is to provide researchers with an updated snapshot of available approaches and their advantages and limitations for production, separation and characterisation of EVs from multiple sources, including cell culture, body fluids and solid tissues. In addition to presenting the latest state of the art in basic principles of EV research, this document also covers advanced techniques and approaches that are currently expanding the boundaries of the field. MISEV2023 also includes new sections on EV release and uptake and a brief discussion of in vivo approaches to study EVs. Compiling feedback from ISEV expert task forces and more than 1000 researchers, this document conveys the current state of EV research to facilitate robust scientific discoveries and move the field forward even more rapidly.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Exosomes / Extracellular Vesicles Language: En Journal: J Extracell Vesicles Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Exosomes / Extracellular Vesicles Language: En Journal: J Extracell Vesicles Year: 2024 Document type: Article Affiliation country: